» Articles » PMID: 33616953

Restricted Mean Survival Time As a Function of Restriction Time

Overview
Journal Biometrics
Specialty Public Health
Date 2021 Feb 22
PMID 33616953
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Restricted mean survival time (RMST) is a clinically interpretable and meaningful survival metric that has gained popularity in recent years. Several methods are available for regression modeling of RMST, most based on pseudo-observations or what is essentially an inverse-weighted complete-case analysis. No existing RMST regression method allows for the covariate effects to be expressed as functions over time. This is a considerable limitation, in light of the many hazard regression methods that do accommodate such effects. To address this void in the literature, we propose RMST methods that permit estimating time-varying effects. In particular, we propose an inference framework for directly modeling RMST as a continuous function of L. Large-sample properties are derived. Simulation studies are performed to evaluate the performance of the methods in finite sample sizes. The proposed framework is applied to kidney transplant data obtained from the Scientific Registry of Transplant Recipients.

Citing Articles

Modeling the Restricted Mean Survival Time Using Pseudo-Value Random Forests.

Schenk A, Basten V, Schmid M Stat Med. 2025; 44(5):e70031.

PMID: 39985373 PMC: 11846141. DOI: 10.1002/sim.70031.


Time-varying effect in older patients with early-stage breast cancer: a model considering the competing risks based on a time scale.

Yu Z, Geng X, Li Z, Zhang C, Hou Y, Zhou D Front Oncol. 2024; 14:1352111.

PMID: 39015489 PMC: 11249566. DOI: 10.3389/fonc.2024.1352111.


Restricted mean survival time regression model with time-dependent covariates.

Zhang C, Huang B, Wu H, Yuan H, Hou Y, Chen Z Stat Med. 2022; 41(21):4081-4090.

PMID: 35746886 PMC: 9545070. DOI: 10.1002/sim.9495.


Nonparametric inference of general while-alive estimands for recurrent events.

Mao L Biometrics. 2022; 79(3):1749-1760.

PMID: 35731993 PMC: 9772359. DOI: 10.1111/biom.13709.

References
1.
Schaubel D, Wei G . Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring. Biometrics. 2010; 67(1):29-38. PMC: 3372067. DOI: 10.1111/j.1541-0420.2010.01449.x. View

2.
Zhong Y, Schaubel D, Kalbfleisch J, Ashby V, Rao P, Sung R . Reevaluation of the Kidney Donor Risk Index. Transplantation. 2018; 103(8):1714-1721. PMC: 6522334. DOI: 10.1097/TP.0000000000002498. View

3.
Uno H, Wittes J, Fu H, Solomon S, Claggett B, Tian L . Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies. Ann Intern Med. 2015; 163(2):127-34. PMC: 4510023. DOI: 10.7326/M14-1741. View

4.
Chen P, Tsiatis A . Causal inference on the difference of the restricted mean lifetime between two groups. Biometrics. 2002; 57(4):1030-8. DOI: 10.1111/j.0006-341x.2001.01030.x. View

5.
Zhang M, Schaubel D . Estimating differences in restricted mean lifetime using observational data subject to dependent censoring. Biometrics. 2010; 67(3):740-9. PMC: 4190616. DOI: 10.1111/j.1541-0420.2010.01503.x. View